Circulating exosomes with overexpressed glypican 1 (GPC1) in the serum of patients closely correlate with pancreatic cancer, which could be used as a highly specific biomarker for pancreatic cancer 5. This evidence concerns the gene GPC1 and familial pancreatic carcinoma.